|
I don’t usually respond on here so I may not be doing this correctly. We had a pt who had to have dilantin IV for months along with TPN infusion. We had difficulty with precipitation. What worked was a dual lumen PICC with one side for TPN and the other for Dilantin and NS only. We gave fosphenytoin which is a more soluble form of IV dilantin.
Debbie Smothers Vascular Access Case Manager The contents of this Email Message and any attachments are confidential and are intended solely for addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply email and delete this message and its attachments, if any. -----Original Message-----
You could create a situation that would destabilize Dilantin enough to crystallize the product. The variables around that situation are significant, but the extreme is precipitation and redissolution from the injection site comparable to IM injection. Not a pleasant thing to have happen, so clearly site selection is critical to successful administration - with success measured as response and consequences. Kostenbauder HB, Rapp RP, McGovren JP, Foster TS, Perrier DG, Blacker HM, Hulon WC, Kinkel AW. Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin. Clin Pharmacol Ther. 1975 Oct;18(4):449-56. Comparison of phenytoin plasma concentrations in an intravenous and intramuscular crossover study in 12 healthy ambulant, male subjects indicates that phenytoin administered intramuscularly is absorbed over a period of approximately five days. A model simulating precipitation and redissolution of the drug at the injection site has been shown to satisfactorily fit observed plasma concentration data following intramuscular administration. It is proposed that this model will be useful in the selection of an appropriate dosing regimen in situations in which intramuscular administration of phenytoin is indicated. marc -----Original Message----- Subject: RE: [vascular] RE: Dilantin No evidence either way according to Marc's response. Lynn At 7:54 PM -0700 2/13/06, Kokotis, Kathy wrote:
-- |
Title: RE: [vascular] RE: Dilantin
- Re: [vascular] RE: Dilantin Martha Pike
- Re: [vascular] RE: Dilantin Lynn Hadaway
- Re: [vascular] RE: Dilantin Heather Nichols
- Re: [vascular] RE: Dilantin Darilyn Cole
- Re: [vascular] RE: Dilantin ccavrn
- Re: [vascular] RE: Dilantin Lynn Hadaway
- RE: [vascular] RE: Dilantin Smothers, Debbie
- Re: [vascular] RE: Dilantin Heather Nichols
- RE: [vascular] RE: Dilantin Lynn Hadaway
- Re: [vascular] RE: Dilantin Lynn Hadaway
- Re: [vascular] RE: Dilantin Heather Nichols
- Re: [vascular] RE: Dilantin Heather Nichols
- RE: [vascular] RE: Dilantin Ward Gina
- RE: [vascular] RE: Dilantin Lynn Hadaway
